The abstract is read at the publisher; the summary is JClub's.
Astrocytic CH25H is elevated in Parkinson’s disease models and is linked to reduced p62/α-synuclein complex formation, while CH25H loss improves α-synuclein clearance and motor deficits in MPTP and PFF mice.
- Why it matters: Inefficient α-synuclein turnover limits clinical translation in Parkinson’s disease, and the mechanisms controlling its degradation—especially in astrocytes—remain unclear.
- What they did: Bulk RNA sequencing of MPTP substantia nigra and reanalysis of patient iPSC-derived astrocyte datasets identified higher CH25H in PD-associated astrocytes, validated by Ch25h/GFAP staining; astrocytic Ch25h knockout/knockdown was tested in MPTP and α-synuclein preformed fibril models, alongside 4D label-free proteomics, docking, and proximity ligation assays.
- The result: CH25H overexpression promoted p62/CH25H complex and inhibited p62/α-synuclein interaction, whereas Ch25h knockdown enhanced p62/α-synuclein complex formation and α-synuclein degradation; 25-hydroxycholesterol did not change α-synuclein expression, and a 60–90 amino acid p62 polypeptide sequestering free CH25H facilitated α-synuclein clearance in cultured astrocytes and PFF mice.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.